The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Intravaginal gene silencing using biodegradable polymer nanoparticles densely loaded with small-interfering RNA
Open accessAbstract
Vaginal instillation of small-interfering RNA (siRNA) using liposomes has led to silencing of endogenous genes in the genital tract and protected against challenge from infectious disease. Although siRNA lipoplexes are easily formulated, several of the most effective transfection agents available commercially may be toxic to the mucosal epithelia and none are able to provide controlled or sustained release. Here, we demonstrate an alternate approach, using nanoparticles composed entirely of FDA-approved materials. To render these materials effective for gene silencing we developed novel approaches to load them with high amounts of siRNA. A single dose of siRNA-loaded nanoparticles to the mouse female reproductive tract caused efficient and sustained gene silencing. Knockdown of gene expression was observed proximal (in the vaginal lumen) and distal (in the uterine horns) to the site of topical delivery. In addition, nanoparticles penetrated deep into the epithelial tissue. This is the first report demonstrating that biodegradable polymer nanoparticles are effective delivery vehicles for siRNA in the vaginal mucosa.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regulated portals of entry into the cell
Conner, S. D., & Schmid, S. L. (2003) · Nature · doi:10.1038/nature01451 · Cited by 3,805
Knocking down barriers: advances in siRNA delivery
Whitehead, K. A., Langer, R., & Anderson, D. G. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2742 · Cited by 3,115
Toxicity of cationic lipids and cationic polymers in gene delivery
Lv, H., Zhang, S., Wang, B., Cui, S., & Yan, J. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.04.014 · Cited by 2,286
Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo
Farokhzad, O. C., Cheng, J., Teply, B. A., Sherifi, I., Jon, S., Kantoff, P. W., Richie, J. P., & Langer, R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601755103 · Cited by 1,663
RNAi-mediated gene silencing in non-human primates
Zimmermann, T. S., Lee, A. C. H., Akinc, A., Bramlage, B., Bumcrot, D., Fedoruk, M. N., Harborth, J., Heyes, J. A., Jeffs, L. B., John, M., et al. (2006) · Nature · doi:10.1038/nature04688 · Cited by 1,357
Polymer microspheres for controlled drug release
Freiberg, S., & Zhu, X. X. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.04.013 · Cited by 1,336
The promises and pitfalls of RNA-interference-based therapeutics
Castanotto, D., & Rossi, J. J. (2009) · Nature · doi:10.1038/nature07758 · Cited by 1,221
Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs
Morrissey, D. V., Lockridge, J. A., Shaw, L., Blanchard, K., Jensen, K., Breen, W., Hartsough, K., Machemer, L., Radka, S., Jadhav, V., et al. (2005) · Nature Biotechnology · doi:10.1038/nbt1122 · Cited by 1,168
Unlocking the potential of the human genome with RNA interference
Hannon, G. J., & Rossi, J. J. (2004) · Nature · doi:10.1038/nature02870 · Cited by 1,064
Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus
Lai, S. K., O'Hanlon, D. E., Harrold, S., Man, S. T., Wang, Y.-Y., Cone, R., & Hanes, J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608611104 · Cited by 1,050
Panyam, J., Zhou, W., Prabha, S., Sahoo, S. K., & Labhasetwar, V. (2002) · The FASEB Journal · doi:10.1096/fj.02-0088com · Cited by 1,044
Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors
Song, E., Zhu, P., Lee, S.-K., Chowdhury, D., Kussman, S., Dykxhoorn, D. M., Feng, Y., Palliser, D., Weiner, D. B., Shankar, P., et al. (2005) · Nature Biotechnology · doi:10.1038/nbt1101 · Cited by 1,021
Current status of polymeric gene delivery systems☆
PARK, T., JEONG, J., & KIM, S. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.03.007 · Cited by 944
Polyamines in cell growth and cell death: molecular mechanisms and therapeutic applications
Thomas*, T., & Thomas, T. J. (2001) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000852 · Cited by 859
siRNA-directed inhibition of HIV-1 infection
Novina, C. D., Murray, M. F., Dykxhoorn, D. M., Beresford, P. J., Riess, J., Lee, S.-K., Collman, R. G., Lieberman, J., Shankar, P., & Sharp, P. A. (2002) · Nature Medicine · doi:10.1038/nm725 · Cited by 773
Sato, Y., Murase, K., Kato, J., Kobune, M., Sato, T., Kawano, Y., Takimoto, R., Takada, K., Miyanishi, K., Matsunaga, T., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1396 · Cited by 609
T Cell-Specific siRNA Delivery Suppresses HIV-1 Infection in Humanized Mice
Kumar, P., Ban, H.-S., Kim, S.-S., Wu, H., Pearson, T., Greiner, D. L., Laouar, A., Yao, J., Haridas, V., Habiro, K., et al. (2008) · Cell · doi:10.1016/j.cell.2008.06.034 · Cited by 570
Diffusion of Macromolecules and Virus-Like Particles in Human Cervical Mucus
Olmsted, S. S., Padgett, J. L., Yudin, A. I., Whaley, K. J., Moench, T. R., & Cone, R. A. (2001) · Biophysical Journal · doi:10.1016/s0006-3495(01)75844-4 · Cited by 544
Systemic Leukocyte-Directed siRNA Delivery Revealing Cyclin D1 as an Anti-Inflammatory Target
Peer, D., Park, E. J., Morishita, Y., Carman, C. V., & Shimaoka, M. (2008) · Science · doi:10.1126/science.1149859 · Cited by 493
JIANG, W., GUPTA, R., DESHPANDE, M., & SCHWENDEMAN, S. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.09.003 · Cited by 478
Panyam, J., & Labhasetwar, V. (2003) · Pharmaceutical Research · doi:10.1023/a:1022219003551 · Cited by 466
Improving protein therapeutics with sustained-release formulations
Putney, S. D., & Burke, P. A. (1998) · Nature Biotechnology · doi:10.1038/nbt0298-153 · Cited by 460
Veazey, R. S., Shattock, R. J., Pope, M., Kirijan, J. C., Jones, J., Hu, Q., Ketas, T., Marx, P. A., Klasse, P. J., Burton, D. R., et al. (2003) · Nature Medicine · doi:10.1038/nm833 · Cited by 460
Breaking up the correlation between efficacy and toxicity for nonviral gene delivery
Breunig, M., Lungwitz, U., Liebl, R., & Goepferich, A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703882104 · Cited by 443
Cationic lipids and polymers mediated vectors for delivery of siRNA
Zhang, S., Zhao, B., Jiang, H., Wang, B., & Ma, B. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.07.016 · Cited by 421
An siRNA-based microbicide protects mice from lethal herpes simplex virus 2 infection
Palliser, D., Chowdhury, D., Wang, Q.-Y., Lee, S. J., Bronson, R. T., Knipe, D. M., & Lieberman, J. (2006) · Nature · doi:10.1038/nature04263 · Cited by 410
Polyamine-dependent gene expression
Childs, A. C., Mehta, D. J., & Gerner, E. W. (2003) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s00018-003-2332-4 · Cited by 402
Caspase 8 small interfering RNA prevents acute liver failure in mice
Zender, L., Hütker, S., Liedtke, C., Tillmann, H. L., Zender, S., Mundt, B., Waltemathe, M., Gösling, T., Flemming, P., Malek, N. P., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1330920100 · Cited by 384
Characterization of cationic lipid-protamine–DNA (LPD) complexes for intravenous gene delivery
Li, S., Rizzo, M., Bhattacharya, S., & Huang, L. (1998) · Gene Therapy · doi:10.1038/sj.gt.3300683 · Cited by 369
Biophysical and Structural Characterization of Polyethylenimine-Mediated siRNA Delivery in Vitro
Richards Grayson, A. C., Doody, A. M., & Putnam, D. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9009-2 · Cited by 324
Veazey, R. S., Klasse, P. J., Schader, S. M., Hu, Q., Ketas, T. J., Lu, M., Marx, P. A., Dufour, J., Colonno, R. J., Shattock, R. J., et al. (2005) · Nature · doi:10.1038/nature04055 · Cited by 298
Punchard, N. A., Whelan, C. J., & Adcock, I. M. (2004) · Journal of Inflammation · doi:10.1186/1476-9255-1-1 · Cited by 259
(D) Routes of delivery: Case studies
Patton, J. S., & Platz, R. M. (1992) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(92)90002-8 · Cited by 249
Misinterpreting the Therapeutic Effects of Small Interfering RNA Caused by Immune Stimulation
Robbins, M., Judge, A., Ambegia, E., Choi, C., Yaworski, E., Palmer, L., McClintock, K., & MacLachlan, I. (2008) · Human Gene Therapy · doi:10.1089/hum.2008.131 · Cited by 220
Implications of pharmacokinetic behavior of lipoplex for its inflammatory toxicity
ZHANG, J., LIU, F., & HUANG, L. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.12.004 · Cited by 195
Khan, A., Benboubetra, M., Sayyed, P. Z., Ng, K. W., Fox, S. P., Beck, G., Benter, I. F., & Akhtar, S. (2004) · Journal of drug targeting · doi:10.1080/10611860400003858 · Cited by 134
Whither or Wither Microbicides?
Grant, R. M., Hamer, D. H., Hope, T. J., Johnston, R., Lange, J. M. A., Lederman, M. M., Lieberman, J., Miller, C. J., Moore, J. P., Mosier, D. E., et al. (2008) · Science · doi:10.1126/science.1160355 · Cited by 131
Anti-tumor effects of anti-VEGF siRNA encapsulated with PLGA microspheres in mice
Murata, N., Takashima, Y., Toyoshima, K., Yamamoto, M., & Okada, H. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.11.017 · Cited by 122
Gu, W., Tom, L. N., Hengst, K., Minto, K., Saunders, N. A., Leggatt, G. R., & McMillan, N. A. J. (2006) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700971 · Cited by 122
Naturally Occurring Polyamines: Interaction with Macromolecules
Bachrach, U. (2005) · Current Protein and Peptide Science · doi:10.2174/138920305774933240 · Cited by 107
The paradoxical effects of using antiretroviral-based microbicides to control HIV epidemics
Wilson, D. P., COPLAN, P. M., Wainberg, M. A., & Blower, S. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711813105 · Cited by 66
Sherwood, J. K., Zeitlin, L., Whaley, K. J., Cone, R. A., & Saltzman, W. M. (1996) · Nature Biotechnology · doi:10.1038/nbt0496-468 · Cited by 60
siRNA Drug Delivery by Biodegradable Polymeric Nanoparticles
Yuan, X., Li, L., Rathinavelu, A., Hao, J., Narasimhan, M., He, M., Heitlage, V., Tam, L., Viqar, S., & Salehi, M. (2006) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2006.436 · Cited by 51
Shen, H. Y., Goldberg, E., & Saltzman, W. M. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00354-1 · Cited by 49
Efficient delivery of small interfering RNA for inhibition of IL-12p40 expression in vivo.
Flynn, M. A., Casey, D. G., Todryk, S. M., & Mahon, B. P. (2004) · Journal of Inflammation · doi:10.1186/1476-9255-1-4 · Cited by 40
Khazanov, E., Simberg, D., & Barenholz, Y. (2006) · The Journal of Gene Medicine · doi:10.1002/jgm.933 · Cited by 28
Several Serum Proteins Significantly Decrease Inflammatory Response to Lipid-based Non-viral Vectors
Conwell, C. C., Liu, F., & Huang, L. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300356 · Cited by 18
Cited by
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
Sun, T., Zhang, Y. S., Pang, B., Hyun, D. C., Yang, M., & Xia, Y. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201403036 · Cited by 2,164
Nanotechnology in Drug Delivery and Tissue Engineering: From Discovery to Applications
Shi, J., Votruba, A. R., Farokhzad, O. C., & Langer, R. (2010) · Nano Letters · doi:10.1021/nl102184c · Cited by 1,612
Crossing the blood-brain barrier with nanoparticles
Zhou, Y., Peng, Z., Seven, E. S., & Leblanc, R. M. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.12.015 · Cited by 837
Delivery of siRNA Therapeutics: Barriers and Carriers
Wang, J., Lu, Z., Wientjes, M. G., & Au, J. L.-S. (2010) · The AAPS Journal · doi:10.1208/s12248-010-9210-4 · Cited by 798
Therapeutic cell engineering with surface-conjugated synthetic nanoparticles
Stephan, M. T., Moon, J. J., Um, S. H., Bershteyn, A., & Irvine, D. J. (2010) · Nature Medicine · doi:10.1038/nm.2198 · Cited by 750
Metadata
- Authors
- Woodrow, K. A., Cu, Y., Booth, C. J., Saucier-Sawyer, J. K., Wood, M. J., & Mark Saltzman, W.
- Venue
- Nature Materials
- Published
- 2009-05-03
- Volume
- 8
- Issue
- 6
- Pages
- 526-533
- ISSN
- 1476-1122 (ISSN-L)
- 1476-4660
- OpenAlex
- W1966962897
- Cited by
- 438
- References
- 47
- FWCI
- 14.52
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.